Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fievet

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Biochemistry|June 1, 1995
Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profileA Mehlum, B Staels, N Duverger, et al.
Gene|April 24, 1995
A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic miceG L Tremp, N Duchange, D Branellec, et al.
American Journal of Nephrology|January 1, 1989
Apolipoprotein B immunochemical heterogeneity in dialysed patients with chronic renal failure and patients with coronary artery stenosisR Reade, V Equagoo, C Cachera, et al.
Clinical Science (London, England : 1979)|February 27, 2001
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemiaA Boullier, N Hennuyer, A Tailleux, et al.
Monographs on Atherosclerosis|January 1, 1985
Mapping of lipoprotein particles with monoclonal antibodies in diabetes and atherosclerosisC Fievet, H Parra, I Luyeye, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibratesA M Lefebvre, J Peinado-Onsurbe, I Leitersdorf, et al.
Atherosclerosis|July 1, 1987
Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosisP Duriez, N Vu Dac, M Koffigan, et al.
Atherosclerosis|December 23, 1998
Branched synthetic peptide constructs mimic cellular binding and efflux of apolipoprotein AI in reconstituted high density lipoproteinsS Nion, L Demoor, C Boutillon, et al.
The Journal of Biological Chemistry|August 10, 2001
Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse linesT E Akiyama, C J Nicol, C Fievet, et al.
The Journal of Biological Chemistry|May 9, 2001
Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrateM Bouly, D Masson, B Gross, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Biochemistry|June 1, 1995
Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profileA Mehlum, B Staels, N Duverger, et al.
Gene|April 24, 1995
A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic miceG L Tremp, N Duchange, D Branellec, et al.
American Journal of Nephrology|January 1, 1989
Apolipoprotein B immunochemical heterogeneity in dialysed patients with chronic renal failure and patients with coronary artery stenosisR Reade, V Equagoo, C Cachera, et al.
Clinical Science (London, England : 1979)|February 27, 2001
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemiaA Boullier, N Hennuyer, A Tailleux, et al.
Monographs on Atherosclerosis|January 1, 1985
Mapping of lipoprotein particles with monoclonal antibodies in diabetes and atherosclerosisC Fievet, H Parra, I Luyeye, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibratesA M Lefebvre, J Peinado-Onsurbe, I Leitersdorf, et al.
Atherosclerosis|July 1, 1987
Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosisP Duriez, N Vu Dac, M Koffigan, et al.
Atherosclerosis|December 23, 1998
Branched synthetic peptide constructs mimic cellular binding and efflux of apolipoprotein AI in reconstituted high density lipoproteinsS Nion, L Demoor, C Boutillon, et al.
The Journal of Biological Chemistry|August 10, 2001
Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse linesT E Akiyama, C J Nicol, C Fievet, et al.
The Journal of Biological Chemistry|May 9, 2001
Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrateM Bouly, D Masson, B Gross, et al.
Pageof 7